Sara A. Illman

563 citations
11 papers · 439 indexed · h-index 9
Topics
Protease and Inhibitor Mechanisms (9 papers)Peptidase Inhibition and Analysis (7 papers)Blood Coagulation and Thrombosis Mechanisms (3 papers)

In The Last Decade

Sara A. Illman

11 papers receiving 426 citations

Peers

Sara A. Illman
Comparison fields: 5 of 77
  • Molecular Biology 217
  • Cancer Research 215
  • Oncology 177
  • Pulmonary and Respiratory Medicine 54
  • Immunology and Allergy 43
Replace S. Carrère with:
S. Carrère France
Kristiann M. Dougherty United States
Mariana Reis-Sobreiro United States
Ella D. Reich Germany
Valérie Edmond France
Masanori Ii Japan
Hyun I. Park United States
Branka Svetic Slovenia
Peter J. Thraves United States
Debbie Hall United Kingdom
Sara A. Illman relative to S. Carrère France S. Carrère's profile →
Citations per field
00.5×4.8×
S. Carrère · 1×
Citations per year

Countries citing papers authored by Sara A. Illman

Since Specialization
Citations

This map shows the geographic impact of Sara A. Illman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara A. Illman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara A. Illman more than expected).

Fields of papers citing papers by Sara A. Illman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara A. Illman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara A. Illman. The network helps show where Sara A. Illman may publish in the future.

Co-authorship network of co-authors of Sara A. Illman

This figure shows the co-authorship network connecting the top 25 collaborators of Sara A. Illman. A scholar is included among the top collaborators of Sara A. Illman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara A. Illman. Sara A. Illman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 22
2 5
3 30
4 55
5
Molecular biology and functions of epilysin (MMP-28)
1
6 133
7 39
8 39
9 39
10 55
11 21

About Sara A. Illman

Sara A. Illman is a scholar working on Cancer Research, Immunology and Allergy and Hematology, having authored 11 papers that have together received 439 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (7 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Cancer Research (215 citations), Immunology and Allergy (43 citations) and Oncology (177 citations). Sara A. Illman has collaborated with scholars based in Finland, United Kingdom and Sweden. Frequent co-authors include Jouko Lohi, Jorma Keski‐Oja, Kaisa Lehti, Lea Sistonen, Marko J. Kallio, J. Peter Slotte, Carina I. Holmberg, Andrey Mikhailov, William C. Parks and Kirsty L. Culley. Their work appears in journals such as Langmuir, Biochemical Journal and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026